Sugarloaf Wealth Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-13
Closed -$2.55K 690
2023
Q3
$2.55K Sell
13
-843
-98% -$173K ﹤0.01% 588
2023
Q2
$180K Buy
856
+402
+89% +$80K 0.04% 148
2023
Q1
$91.7K Buy
454
+160
+54% +$36.3K 0.02% 207
2022
Q4
$64K Sell
294
-10
-3% -$2.18K 0.02% 249
2022
Q3
$60K Buy
304
+19
+7% +$4.1K 0.02% 261
2022
Q2
$61K Buy
285
+72
+34% +$17.6K 0.02% 256
2022
Q1
$60K Buy
213
+59
+38% +$18.2K 0.01% 253
2021
Q4
$58K Buy
154
+98
+175% +$38.1K 0.01% 269
2021
Q3
$23K Buy
+56
New +$23.3K 0.01% 396

Other funds holding CRL